[go: up one dir, main page]

ES2053606T3 - Metodo de preparacion de un inhibidor de alfa-1-proteinasa de alta pureza. - Google Patents

Metodo de preparacion de un inhibidor de alfa-1-proteinasa de alta pureza.

Info

Publication number
ES2053606T3
ES2053606T3 ES88106017T ES88106017T ES2053606T3 ES 2053606 T3 ES2053606 T3 ES 2053606T3 ES 88106017 T ES88106017 T ES 88106017T ES 88106017 T ES88106017 T ES 88106017T ES 2053606 T3 ES2053606 T3 ES 2053606T3
Authority
ES
Spain
Prior art keywords
proteinase inhibitor
preparation
high purity
purity alpha
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88106017T
Other languages
English (en)
Inventor
Michael A Shearer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Application granted granted Critical
Publication of ES2053606T3 publication Critical patent/ES2053606T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8125Alpha-1-antitrypsin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A UN INHIBIDOR DE ALFA-1-PROTEINASA CONCENTRADO ALTAMENTE PURIFICADO, Y A UN METODO DE SEPARACION DE PROTEINAS QUE TIENEN ENLACES DISULFURO, CON AGENTES REDUCTORES SUAVES Y A UNA TEMPERATURA SUFICIENTE PARA IMPEDIR LA REAGRUPACION DE LAS PROTEINAS REDUCIDAS. ESTE METODO SE PUEDE COMBINAR CON UN PROCESO DE INACTIVACION TERMICO.
ES88106017T 1987-04-27 1988-04-15 Metodo de preparacion de un inhibidor de alfa-1-proteinasa de alta pureza. Expired - Lifetime ES2053606T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4292587A 1987-04-27 1987-04-27

Publications (1)

Publication Number Publication Date
ES2053606T3 true ES2053606T3 (es) 1994-08-01

Family

ID=21924478

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88106017T Expired - Lifetime ES2053606T3 (es) 1987-04-27 1988-04-15 Metodo de preparacion de un inhibidor de alfa-1-proteinasa de alta pureza.

Country Status (8)

Country Link
EP (1) EP0288841B1 (es)
JP (1) JPS63309189A (es)
AT (1) ATE84041T1 (es)
AU (1) AU608832B2 (es)
CA (1) CA1340236C (es)
DE (1) DE3877041T2 (es)
ES (1) ES2053606T3 (es)
GR (1) GR3007058T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749783A (en) * 1986-07-11 1988-06-07 Miles Laboratories, Inc. Viral inactivation and purification of active proteins
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
US6887678B2 (en) * 1998-12-02 2005-05-03 Cindy L. Bristow Method for the quantitative determination of proteinase inhibitors
US7777006B2 (en) * 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
BRPI0412835A (pt) * 2003-08-12 2006-09-26 Octapharma Ag processo para preparação de uma solução de alfa-1-antitripsina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS584728A (ja) * 1981-05-01 1983-01-11 メデイカル・リサ−チ・インステイチユ−ト・オブ・サンフランシスコ・コ−ポレ−シヨン α−1−抗トリプシンの精製
DE3271827D1 (en) * 1981-05-01 1986-07-31 Medical Research Inst Of San F Method for isolating alpha-1-antitrypsin
US4439358A (en) * 1982-06-17 1984-03-27 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4470968A (en) * 1983-01-13 1984-09-11 Miles Laboratories, Inc. Pasteurized therapeutically active blood coagulation factor concentrates

Also Published As

Publication number Publication date
AU1516988A (en) 1988-10-27
DE3877041D1 (de) 1993-02-11
EP0288841A3 (en) 1989-05-17
EP0288841B1 (en) 1992-12-30
ATE84041T1 (de) 1993-01-15
DE3877041T2 (de) 1993-04-22
AU608832B2 (en) 1991-04-18
GR3007058T3 (es) 1993-07-30
JPS63309189A (ja) 1988-12-16
CA1340236C (en) 1998-12-15
EP0288841A2 (en) 1988-11-02

Similar Documents

Publication Publication Date Title
GR3006427T3 (es)
NO180718C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive mercaptoacetylamidderivater
FI945549L (fi) Deoksiribonukleaasin puhdistetut muodot
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
FI932736A0 (fi) Behandlingsfoerfarande foer livsmedelsprodukter och -biprodukter
ATE96784T1 (de) Verfahren zur reinigung von tryptophan.
DE59308628D1 (de) Verfahren zur Herstellung von Faktor VIII
ES2053606T3 (es) Metodo de preparacion de un inhibidor de alfa-1-proteinasa de alta pureza.
PL286043A1 (en) Method for manufacturing new proteins
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
GR3006419T3 (es)
DE3467340D1 (en) Process for purification of 1,2-unsaturated carboxylic acids and/or esters thereof
FR2562442B1 (fr) Procede pour la purification d'un gaz d'echappement
DE3273177D1 (en) Trans-dihyldrolisuride antipsychotic
FI871078A7 (fi) Menetelmä ja seos bronkospastisten hengitystietautien hoitamiseksi.
ES536028A0 (es) Un procedimiento para producir interferon inmune humano recombinante intacto

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 288841

Country of ref document: ES